Received Jun 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
the second was postponed twice due to surgeries; This spontaneous report was received from a 44-year-old female patient, referring to herself. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 29-DEC-2024, the patient was vaccinated with 1st dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection, administered for prophylaxis (dose, route of administration, anatomical location, lot # and expiration date were not reported). The 2nd dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) was postponed twice due to unspecified surgeries (performed on unspecified dates). The outcome of the event was not reported. Causality assessment was not provided. Additional information is not expected.